Enregistrement :
15
de
40
(2015-01-05
à
2015-01-07)
Politique ou Programme
Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement
Politique ou Programme, Proposition législative, Projet de loi ou résolution
Pharmaceutical intellectual property proposals that are part of the Comprehensive Economic and Trade Agreement with the European Union.
Politique ou Programme, Proposition législative, Projet de loi ou résolution, Règlement
Acts that propose to amend the Food and Drug Act and amendments to the Food and Drug Regulations related to the regulation of pharmaceuticals, biologic therapies, medical devices and foods.
Proposition législative, Projet de loi ou résolution, Règlement
Similar Entry Biologics (SEBs): requiring a Health Canada regulatory framework that support the approval of SEBs
Règlement
Industry Canada Patented Medicines Notice of Compliance (PMNOC) Regulations, as this relates to regulating intellectual property of prescription drugs
Patented Medicine Prices Review Board (PMPRB) Regulations.
with regard to prices charged by patentees for patented medicines sold in Canada.